Interaction between dopaminergic and serotonergic systems.

Functional Interplay between Dopaminergic and Serotonergic Neuronal Systems during Development and Adulthood.

Lateral habenula as a link between dopaminergic and serotonergic systems contributes to depressive symptoms in Parkinson's disease.

Cross interaction of melanocortinergic and dopaminergic systems in neural modulation.

Cross interaction of dopaminergic and adrenergic systems in neural modulation.

Serotonergic and dopaminergic involvement in ethanol intake.

Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence.

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems.

A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.

The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide.

The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility.

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease.

Molecular Signatures of Natural Selection for Polymorphic Genes of the Human Dopaminergic and Serotonergic Systems: A Review.

The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

Interrelationship between NO and androgenic activity in mice, Mus musculus, following temporal phase relation of serotonergic and dopaminergic neural oscillations.

Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems.

Interaction between auditory and motor systems in speech perception.

Interaction between ABO and haptoglobin systems in a Bengalee population.

The interaction of acetylcholinergic and serotonergic neural systems on performance in a continuous non-matching to sample task.

Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage.

Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.

Dopaminergic and serotonergic activity in the hypothalamus during early and late pregnancy.

Pharmacological evidence for dopaminergic pallido-striatal interaction.

Suggest Documents

Functional Interplay between Dopaminergic and Serotonergic Neuronal Systems during Development and Adulthood.

Lateral habenula as a link between dopaminergic and serotonergic systems contributes to depressive symptoms in Parkinson's disease.

Cross interaction of melanocortinergic and dopaminergic systems in neural modulation.

Cross interaction of dopaminergic and adrenergic systems in neural modulation.

Serotonergic and dopaminergic involvement in ethanol intake.

Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence.

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems.

A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.

The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide.

The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility.

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease.

Molecular Signatures of Natural Selection for Polymorphic Genes of the Human Dopaminergic and Serotonergic Systems: A Review.

The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

Interrelationship between NO and androgenic activity in mice, Mus musculus, following temporal phase relation of serotonergic and dopaminergic neural oscillations.

Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems.

Interaction between auditory and motor systems in speech perception.

Interaction between ABO and haptoglobin systems in a Bengalee population.

The interaction of acetylcholinergic and serotonergic neural systems on performance in a continuous non-matching to sample task.

Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage.

Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.

Dopaminergic and serotonergic activity in the hypothalamus during early and late pregnancy.

Pharmacological evidence for dopaminergic pallido-striatal interaction.

Interaction between dopaminergic and serotonergic systems.

Recommend Documents

Follow Us